Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Gut 2006;55:1379-1381; doi:10.1136/gut.2006.098806
Copyright © 2006 BMJ Publishing Group Ltd & British Society of Gastroenterology

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Galmiche, J P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galmiche, J P
Topic Collections
Right arrowRelevant Article

COMMENTARY

Oesophagus

Impedance-pH monitoring in proton pump inhibitor resistant patients: ready for clinical application?

J P Galmiche

Correspondence to:
Correspondence to:
Professor J P Galmiche
Institut des Maladies de l’Appareil Digestif, University Hospital Hôtel-Dieu, 44093 Nantes, France; jeanpaul.galmiche@chu-nantes.fr


Impedance-pH monitoring represents a useful tool for studies and clinical research in oesophageal disorders, and may hold promise for the group of patients dissatisfied with their antireflux treatment

Keywords: multichannel intraluminal impedance and pH; gastro-oesophageal reflux disease; non-acid reflux; proton pump inhibitor; symptom analysis

The first 150 words of the full text of this article appear below.

Gastro-oesophageal reflux disease (GORD) is a very common disorder in which the reflux of gastric (or gastroduodenal) contents causes troublesome symptoms and/or lesions of the oesophageal mucosa. The harmful effects of acid injury on the oesophageal mucosa have been established for decades by experimental and clinical studies.1 From a clinical and therapeutic viewpoint, the central role of acid in the pathogenesis of reflux symptoms and lesions of the oesophagitis was most convincingly confirmed by the introduction of acid suppressive therapy; the development of proton pump inhibitors (PPIs) achieved a level of efficacy not previously reached by antacids or H2 blockers.2

Despite the progress made with PPIs, it has now however become clear that up to 40% of patients with GORD symptoms are either not completely satisfied with their acid suppressive therapy or may be resistant to PPIs.3 Several reasons may underlie an individual’s resistance to his or her PPI . . . [Full text of this article]


Relevant Article

Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring
I Mainie, R Tutuian, S Shay, M Vela, X Zhang, D Sifrim, and D O Castell
Gut 2006 55: 1398-1402. [Abstract] [Full Text] [PDF]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 BMJ Publishing Group Ltd & British Society of Gastroenterology